Robin Hutchison - BiOasis Technologies Founder, Executive Chairman, CEO and Pres
| BIOAF Stock | USD 0 0 33.33% |
Chairman
Mr. Robin B. Hutchison is no longer Executive Chairman of the Board of biOasis Technologies Inc. Mr. Hutchison is the founder of several companies including eCharge Corporation of Seattle, Washington, which specializes in alternative payment methods for the internet. He served as the President and Chief Scientist of eCharge . Mr. Hutchison pioneered and holds the patents on unique digital certificate technology, which enabled eCharge to provide secure Internet commerce transactions. Prior to cofounding eCharge, Mr. Hutchison was the President of Canadabased SNI Corporation, which specializes in the integration of SUN Microsystems UNIXbased systems with the Internet and computer firewall security. He also served as the Western regional director of sales and operations for Everex Canada Inc. Mr. Hutchison is currently a director of bioMmune Technologies Inc. and was previously a director of the following companies Golden Goliath Resources Inc., Rocketinfo Inc., Serebra Learning Corporation and Kree Tech International Corporationrationration. since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 203 533 7082 |
| Web | https://www.bioasis.us |
BiOasis Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8058) % which means that it has lost $0.8058 on every $100 spent on assets. This is way below average. BiOasis Technologies' management efficiency ratios could be used to measure how well BiOasis Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Eric Weisblum | Silo Pharma | 54 | |
| Garo Armen | Protagenic Therapeutics | 71 | |
Management Performance
| Return On Asset | -0.81 |
biOasis Technologies Leadership Team
Elected by the shareholders, the BiOasis Technologies' board of directors comprises two types of representatives: BiOasis Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BiOasis. The board's role is to monitor BiOasis Technologies' management team and ensure that shareholders' interests are well served. BiOasis Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BiOasis Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Terry Pearson, Independent Director | ||
| David Wurzer, Independent Director | ||
| Doug Williams, Executive Vice-President Chief Business Officer | ||
| Greg Gubitz, Independent Director | ||
| Michael Hutchison, Independent Director | ||
| Christian Fibiger, Independent Director | ||
| Nancy Stagliano, Director | ||
| Mario Saltarelli, Non-Executive Director | ||
| Judi Dalling, CFO and Corporate Secretary | ||
| Graeme Dick, Director Relations | ||
| Doug MBA, Exec Officer | ||
| Christine Antalik, CFO | ||
| John Curran, Independent Director | ||
| Kim Elton, Director Marketing | ||
| Ronald Erickson, Independent Director | ||
| Deborah Rathjen, Director | ||
| Mei Tian, VP Research | ||
| Mark Day, President CEO, Director | ||
| Mahalakshmi Radhakrishnan, Director | ||
| Dave Jenkins, Chief Officer | ||
| Christopher Lowe, CFO | ||
| B FTSE, CEO Chairman | ||
| Robin Hutchison, Founder, Executive Chairman, CEO and Pres |
BiOasis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BiOasis Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.81 | |||
| Operating Margin | (11.41) % | |||
| Current Valuation | 6 M | |||
| Shares Outstanding | 79.41 M | |||
| Shares Owned By Insiders | 2.05 % | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 53.47 X | |||
| Price To Sales | 26.52 X | |||
| Revenue | 37.73 K | |||
| Gross Profit | (1.15 M) |
Pair Trading with BiOasis Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiOasis Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with BiOasis Pink Sheet
| 0.62 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
Moving against BiOasis Pink Sheet
| 0.56 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.44 | MCD | McDonalds Financial Report 25th of July 2024 | PairCorr |
The ability to find closely correlated positions to BiOasis Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiOasis Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiOasis Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling biOasis Technologies to buy it.
The correlation of BiOasis Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiOasis Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if biOasis Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiOasis Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biOasis Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the biOasis Technologies information on this page should be used as a complementary analysis to other BiOasis Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for BiOasis Pink Sheet analysis
When running BiOasis Technologies' price analysis, check to measure BiOasis Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOasis Technologies is operating at the current time. Most of BiOasis Technologies' value examination focuses on studying past and present price action to predict the probability of BiOasis Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOasis Technologies' price. Additionally, you may evaluate how the addition of BiOasis Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |